[Pharmacological management of rheumatoid arthritis: the state of the art and the future perspective].

Hideto Kameda, Tsutomu Takeuchi

研究成果: Review article査読

1 被引用数 (Scopus)

抄録

Pharmacological management of rheumatoid arthritis (RA) has been rapidly progressed in recent years, which is appeared in the "treat to target" movement and the recommendations developed by some established international/domestic rheumatology associations. The baseline evaluation of poor prognostic factors as well as disease activity with composite measures is necessary for a personalized management. Methotrexate is currently the anchor drug, and other conventional or biological antirheumatic drugs should be added to it for refractory patients. The development of various novel agents including signal transduction inhibitors should promote further advances in the management of RA and other systemic autoimmune and/or inflammatory diseases.

本文言語English
ページ(範囲)1166-1171
ページ数6
ジャーナルUnknown Journal
71
7
出版ステータスPublished - 2013 7
外部発表はい

ASJC Scopus subject areas

  • 医学(全般)

フィンガープリント

「[Pharmacological management of rheumatoid arthritis: the state of the art and the future perspective].」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル